Search research articles
Contact Us
Filters
Showing results (71-80 of 265) with videos related to
Page
of 27
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 15, 2006
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome
Deborah A Hall, Elizabeth Berry-Kravis, Randi J Hagerman, et al.
Neurology. Genetics
|
April 12, 2016
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
Deborah A Hall, Erin E Robertson-Dick, Joan A O'Keefe, et al.
American Journal of Medical Genetics. Part A
|
February 11, 2022
The association between mosaicism type and cognitive and behavioral functioning among males with fragile X syndrome
Lu Meng, Walter E Kaufmann, Richard E Frye, et al.
Plos One
|
February 14, 2020
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
Deborah A Hall, Erin E Robertson, Maureen Leehey, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 27, 2014
Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome
Cicely Kerr, Katie Breheny, Andrew Lloyd, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
The Corpus Callosum Splenium Sign in Fragile X-Associated Tremor Ataxia Syndrome
Deborah A Hall, Meghan Hermanson, Emily Dunn, et al.
Neurocase
|
April 5, 2005
The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment
Neelum T Aggarwal, Robert S Wilson, Todd L Beck, et al.
Gait & Posture
|
November 21, 2013
Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome
Joan A O'Keefe, Alejandro A Espinoza Orías, Hassan Khan, et al.
Neurology
|
May 1, 2015
White matter disease and cognitive impairment in FMR1 premutation carriers
Christopher M Filley, Mark S Brown, Karen Onderko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 21, 2011
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations
Jennifer G Goldman, Darcy Marr, Lili Zhou, et al.
Page
of 27
Search research articles
Search
Showing results (71-80 of 265) with videos related to
Sort By:
Page
of 27
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 15, 2006
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome
Deborah A Hall, Elizabeth Berry-Kravis, Randi J Hagerman, et al.
Neurology. Genetics
|
April 12, 2016
X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
Deborah A Hall, Erin E Robertson-Dick, Joan A O'Keefe, et al.
American Journal of Medical Genetics. Part A
|
February 11, 2022
The association between mosaicism type and cognitive and behavioral functioning among males with fragile X syndrome
Lu Meng, Walter E Kaufmann, Richard E Frye, et al.
Plos One
|
February 14, 2020
Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
Deborah A Hall, Erin E Robertson, Maureen Leehey, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 27, 2014
Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome
Cicely Kerr, Katie Breheny, Andrew Lloyd, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
The Corpus Callosum Splenium Sign in Fragile X-Associated Tremor Ataxia Syndrome
Deborah A Hall, Meghan Hermanson, Emily Dunn, et al.
Neurocase
|
April 5, 2005
The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment
Neelum T Aggarwal, Robert S Wilson, Todd L Beck, et al.
Gait & Posture
|
November 21, 2013
Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome
Joan A O'Keefe, Alejandro A Espinoza Orías, Hassan Khan, et al.
Neurology
|
May 1, 2015
White matter disease and cognitive impairment in FMR1 premutation carriers
Christopher M Filley, Mark S Brown, Karen Onderko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 21, 2011
Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations
Jennifer G Goldman, Darcy Marr, Lili Zhou, et al.
Page
of 27